Avalo Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -50.6% | -43.4% | +111.1% | -58.9% | +15,766.7% | -82.1% | +6.7% | -14.8% | +22.3% | +8.6% | -17.8% | +26.2% | -255.4% | – | -51.4% | -17.0% | +34.7% | -68.4% | +609.3% | -59.8% | -83.8% | +435.6% | -11.9% | +1,347.1% | -94.0% | -47.0% | +35.4% | -63.3% | +141.9% | -100.0% | – | – | -22.9% | -100.0% | – | – | – | -100.0% | – | – | |
| – | +105.5% | -89.7% | +22.9% | -54.1% | +134.6% | +55.3% | +64.8% | +118.6% | -33.1% | -6.4% | +65.1% | -55.4% | -365.3% | – | +18.2% | -1.3% | +13,680.5% | -99.3% | +12,832.5% | -90.9% | +864.8% | -91.8% | +117.6% | -66.3% | +17.4% | +703.7% | -85.8% | -66.1% | -192.1% | – | – | -308.2% | – | +6,695.4% | +80.3% | -6.3% | -99.8% | +6.3% | – | – | |
| – | – | – | – | – | – | -85.2% | -7.1% | -71.3% | +201.4% | +19.3% | -64.4% | +238.8% | -217.7% | – | -53.1% | -17.9% | -981.4% | – | -1,767.4% | – | -2,032.4% | – | -217.9% | – | -98.1% | -1,733.3% | – | – | – | -94.2% | -845.7% | – | -89.1% | -5,730.5% | – | – | – | -128.8% | – | – | |
| – | +83.1% | -83.1% | +23.3% | -48.2% | +95.4% | +71.0% | -34.4% | -3.2% | +91.5% | +69.5% | +9.2% | -53.0% | +66.7% | +64.0% | +24.1% | +49.9% | +42.4% | +99.5% | -50.1% | -16.1% | +9.1% | -16.7% | -11.2% | -17.3% | -12.4% | -2.7% | -22.5% | -73.2% | +49.5% | +13.3% | +122.3% | +102.8% | -14.2% | +11.5% | +54.3% | -3.2% | -2.6% | +5.9% | +66.7% | – | |
| – | +4.1% | -35.7% | +21.5% | +8.2% | +49.5% | +35.6% | +4.2% | -38.1% | +50.9% | -4.4% | -12.3% | +12.5% | -12.5% | +14.1% | +128.0% | -25.0% | -1.1% | +8.6% | +42.0% | -21.9% | -20.6% | +125.6% | -71.6% | +18.3% | -10.1% | -8.6% | -10.2% | +2.9% | +7.2% | +19.4% | +41.5% | -8.1% | +7.2% | +24.5% | -6.3% | +7.1% | +10.8% | +11.1% | +16.6% | – | |
| – | +51.9% | -70.3% | +22.2% | -15.4% | +61.2% | +128.2% | +4.1% | -14.7% | +37.9% | +18.5% | -1.9% | -20.0% | -167.9% | – | -61.7% | +9.5% | +345.3% | -51.4% | -35.5% | -15.4% | -44.3% | +126.1% | -47.0% | -8.6% | -11.6% | -53.1% | +65.4% | -47.1% | +21.3% | +16.1% | +75.0% | +49.7% | -3.0% | -34.7% | -1.2% | +6.4% | +115.0% | +5.5% | +50.9% | – | |
| – | – | – | – | – | – | -115.9% | – | – | – | – | – | – | – | -5,548.2% | – | – | – | – | – | – | – | – | – | – | -316.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -17.9% | -20.3% | -30.4% | -55.6% | +14.7% | +241.7% | +141.4% | -3.1% | -0.4% | -11.1% | -3.9% | +3.1% | +256.9% | -98.7% | -11.0% | – | – | -8.1% | +1,305.9% | +312.1% | +20.2% | -1.3% | -1.3% | -22.2% | +5.7% | +0.0% | +5.0% | +55.9% | -94.8% | – | – | -7.2% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -117.6% | – | – | – | – | – | – | – | -1,894.6% | – | – | – | – | – | – | – | – | – | – | -406.7% | – | – | – | – | – | – | -76.6% | -253.0% | – | – | – | – | – | – | – | |
| – | +468.7% | -126.0% | – | -61.8% | +13,633.0% | -99.3% | -29.9% | +220.5% | -340.4% | – | -60.1% | +74.1% | -158.9% | – | – | – | -6,300.0% | – | +1,709.1% | -96.0% | +100.0% | -43.7% | -44.4% | +0.0% | +60.0% | +0.0% | -12.5% | +14.3% | -212.5% | – | +0.0% | -300.0% | – | -93.0% | +100.0% | -31.3% | +1,081.8% | -90.8% | +50.0% | – | |
| – | – | – | – | – | – | -120.7% | – | – | – | – | – | – | – | -1,402.7% | – | – | – | – | – | – | – | – | – | – | -407.4% | – | – | – | – | – | – | -76.6% | -253.4% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -112.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -313.6% | – | – | – | – | – | – | -76.6% | -252.5% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.